Endoscope Reprocessing Market Summary

The global endoscope reprocessing market size was estimated at USD 1.71 billion in 2024 and is projected to reach USD 3.02 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.64% from 2025 to 2033. The market is primarily driven by the rising incidence of infections caused by contaminated endoscopes and the growing preference for minimally invasive surgical procedures. Effective reprocessing of endoscopes ensures patient safety and reduces the risk of healthcare-associated infections, making it an essential component of medical facility operations worldwide.

A study titled "Cannulation rates and technical performance evaluation of commercially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis," published in January 2024, reported that infection rates associated with duodenoscopes ranged from 0.4% to 1%. These statistics highlight the critical need for reliable and effective endoscope reprocessing solutions to prevent infection transmission and maintain high standards of patient care.

Key Market Trends & Insights

• In 2024, North America dominated the global endoscope reprocessing market, accounting for the largest revenue share of 38.3%. The region’s leadership is attributed to advanced healthcare infrastructure, stringent regulatory requirements, and high adoption of minimally invasive procedures that necessitate proper endoscope reprocessing.
• The Canada market is anticipated to register the fastest growth rate during the forecast period, driven by increasing healthcare investments, rising awareness about infection control, and expanding adoption of endoscope reprocessing solutions across medical facilities.
• By product, the high-level disinfectants and test strips segment held the largest revenue share in 2024, reflecting their critical role in ensuring effective sterilization, monitoring, and validation of reprocessing procedures in hospitals, clinics, and ambulatory surgical centers.
• By end-use, the ambulatory surgical centers (ASCs) segment accounted for the largest revenue share in 2024, highlighting the growing demand for outpatient procedures and the need for reliable endoscope reprocessing solutions in these settings to maintain patient safety and operational efficiency.

Order a free sample PDF of the Endoscope Reprocessing Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.71 Billion
• 2033 Projected Market Size: USD 3.02 Billion
• CAGR (2025-2033): 6.64%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key market participants focus on devising innovative business growth strategies in product portfolio expansions, partnerships & collaborations, mergers & acquisitions, and business footprint expansions.

Key Players

• Cantel Medical
• Fortive Corporation (Advanced Sterilization Products)
• Olympus Corporation
• Ecolab
• Getinge AB
• STERIS
• Steelco S.p.A
• ARC Group of Companies Inc.
• Metrex Research, LLC.
• Shinva Medical Instrument Co., Ltd.
• Belimed

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global endoscope reprocessing market is poised for steady growth, driven by the increasing prevalence of healthcare-associated infections, rising demand for minimally invasive procedures, and stringent infection control regulations. North America currently leads the market, while Canada is expected to grow at the fastest rate during the forecast period. High-level disinfectants and test strips are essential products, and ambulatory surgical centers remain the largest end-use segment. As healthcare providers prioritize patient safety and infection prevention, endoscope reprocessing solutions will continue to play a critical role in reducing infection risks, ensuring compliance, and supporting safe, efficient surgical care worldwide.